Reza Oliyai

2.4k citations
21 papers · 1.8k indexed · 1 hit paper · h-index 13

Reza Oliyai

19 papers receiving 1.8k citations

Hit Papers

Prodrugs: design and clinical applications1.2k20082026201420204008001.2k

Peers

Reza Oliyai
Comparison fields: 5 of 109
  • Pharmaceutical Science 207
  • Virology 115
  • Infectious Diseases 327
  • Biomaterials 230
  • Organic Chemistry 434
Replace John M. Hilfinger with:
John M. Hilfinger United States
Antonio Garofalo Italy
Mehran Yazdanian United States
Hanna Kumpulainen Finland
Doo-Man Oh United States
Aiming Sun United States
Anand K. Kondapi India
Margherita Brindisi Italy
Claude Monneret France
Benoît Déprez France
Reza Oliyai relative to John M. Hilfinger United States John M. Hilfinger's profile →
Citations per field
00.5×2.7×
John M. Hilfinger · 1×
Citations per year

Countries citing papers authored by Reza Oliyai

Since Specialization
Citations

This map shows the geographic impact of Reza Oliyai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reza Oliyai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reza Oliyai more than expected).

Fields of papers citing papers by Reza Oliyai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reza Oliyai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reza Oliyai. The network helps show where Reza Oliyai may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Reza Oliyai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Reza Oliyai Line = papers co-authored together Reza Oliyai links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20220
3 20121
4
Prodrugs: design and clinical applicationsbreakdown →
20081236
5 200789
6 20015
7 20018
8 200127
9 199918
10 19993
11 19989
12 1997102
13 199795
14 199637
15 199512
16 199416
17 199337
18 199357
19 199227
20 199123

About Reza Oliyai

Reza Oliyai is a scholar working on Filtration and Separation, Infectious Diseases and Pharmaceutical Science, having authored 21 papers that have together received 1.8k indexed citations. Recurring topics across this work include Protein purification and stability (7 papers), HIV/AIDS drug development and treatment (7 papers), RNA Interference and Gene Delivery (5 papers), Chemical Synthesis and Analysis (4 papers), Biochemical and Molecular Research (4 papers), Click Chemistry and Applications (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Pharmaceutical Science (207 citations), Virology (115 citations) and Infectious Diseases (327 citations). Reza Oliyai has collaborated with scholars based in United States, Belgium and Denmark. Frequent co-authors include Tomi Järvinen, Hanna Kumpulainen, Tycho Heimbach, Doo-Man Oh, Jarkko Rautio, Jouko Savolainen, Valentino J. Stella, William A. Lee, Murty N. Arimilli and Kenneth C. Cundy. Their work appears in journals such as SHILAP Revista de lepidopterología, Nature Reviews Drug Discovery and Advanced Drug Delivery Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026